Australian study identifies early blood marker for lung cancer risk
Australian researchers have identified a 14-protein blood signature that can predict lung cancer risk up to five years before a diagnosis. This discovery could enable earlier medical intervention and more effective screening for both smokers and non-smokers.
Why it matters
Early detection of lung cancer significantly improves survival rates, and this biomarker could revolutionize preventative screening protocols globally.
A newly identified blood signature may predict lung cancer risk more than five years before diagnosis, offering a potential pathway to earlier prevention, a study has revealed.
The article is a standard scientific reporting piece based on peer-reviewed research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in